Sign in

You're signed outSign in or to get full access.

Robert Machinist

Director at ECD Automotive Design
Board

About Robert Machinist

Robert Machinist, age 72, serves as an independent director of ECD Automotive Design (ECDA). He is a seasoned investor and operator with senior leadership experience across investment banking and credit management, and holds a B.A. in Philosophy and Chemistry from Vassar College with graduate work in biochemistry at the Weizmann Institute of Science. He is a Class I director with a term expiring at the 2027 annual meeting. His background includes CEO/Chairman of Troika Media Group and senior roles at Bank of New York Capital Markets and Patricof & Co. Capital Corp.

Past Roles

OrganizationRoleTenureCommittees/Impact
Troika Media Group (Nasdaq: TRKA)Chief Executive Officer and ChairmanMar 2018 – May 2022Led public media/marketing company
Atlantic International Corp.Chairman of the BoardSince Oct 2022Ongoing board leadership
Pyrolyx A.G. (S26.DU)Vice Chairman2014 – 2018Sustainability/recycling (carbon black)
CIFC Corp. (Nasdaq: CIFC)Chairman; Founding Board MemberThrough Dec 2016 (company sold)Publicly listed credit manager ($14B AUM)
MESA (sold to Houlihan Lokey in 2016)Chairman, Board of AdvisorsThrough 2016 (company sold)Media and entertainment merchant banking
Columbus NovaPartnerNot disclosedPrivate investment fund partner
Bank of New York & Capital MarketsManaging Director; Head of Investment BankingNov 1999 – Dec 2002Led IB franchise
Patricof & Co. Capital Corp. (APAX Purchasers)President; Principal FounderApr 1986 – Nov 1999Built and led private equity advisory platform

External Roles

OrganizationRoleTenureCommittees/Impact
Weizmann Institute of ScienceChairman, International BoardCurrentGlobal institutional governance
Maimonides Medical CenterChairman, Investment CommitteeCurrentOversees investment policy/portfolio
Vassar CollegeTrustee; Vice Chairman; Executive CommitteePast/Current as disclosedOne of three trustees managing endowment
Parachute Health, LLCBoard MemberCurrentHealth-tech board service

Board Governance

  • Independence: The Board determined that Robert Machinist is an independent director under Nasdaq rules.
  • Committee assignments and roles:
    • Nominating Committee: Chair (members: Machinist, Lavelle, Wood).
    • Audit Committee: Member (Chair: Thomas Wood; members: Wood, Machinist, Lavelle).
    • Compensation Committee: Member (Chair: Patrick Lavelle; members: Lavelle, Machinist, Wood).
  • Attendance: Each director attended at least 75% of the aggregate of Board and applicable committee meetings in the last fiscal year.
  • Board structure: Classified Board; Machinist is a Class I director with term expiring at the 2027 annual meeting.

Fixed Compensation

ComponentAmount/Terms
Board meeting fee (non-employee directors)$12,500 per quarterly meeting attended; maximum $50,000 per year.

Performance Compensation

InstrumentGrant SizeExercise PriceNotes
One-time stock option grant (non-employee directors)Up to 15,000 options110% of Common Stock price per share at Closing DateImplemented following the Business Combination; individual director award details not itemized in proxy.

Other Directorships & Interlocks

TypeCompanyRoleDates/Status
Current (as disclosed)Atlantic International Corp.ChairmanSince Oct 2022 (listing status not specified)
Current (private)Parachute Health, LLCDirectorCurrent
Prior publicTroika Media Group (Nasdaq: TRKA)CEO & ChairmanMar 2018 – May 2022
Prior publicCIFC Corp. (Nasdaq: CIFC)Chairman; Founding Board MemberThrough Dec 2016 (sold)
Prior international listingPyrolyx A.G. (S26.DU)Vice Chairman2014 – 2018

Expertise & Qualifications

  • Principal investor/operator with multi-sector experience; former head of investment banking at Bank of New York Capital Markets and president/founder at Patricof & Co. Capital Corp. (APAX Purchasers).
  • Public company leadership as CEO/Chairman (TRKA) and credit manager board leadership (CIFC).
  • Governance leadership including chairing nominating committee at ECDA and chairing major institutional boards (Weizmann International Board; Maimonides Investment Committee).
  • Education: B.A. (Philosophy and Chemistry), Vassar College; graduate work in biochemistry, Weizmann Institute of Science.

Equity Ownership

HolderShares Beneficially OwnedOwnership % (of 47,582,259 O/S as of Jul 2, 2025)
Robert Machinist50,000Less than 1%

Governance Assessment

  • Positives for investor confidence:

    • Independent director with multi-committee service and chair of Nominating Committee, which oversees director qualifications, committee structure, succession planning, and related-party transaction policy—supports board independence and oversight rigor.
    • Audit and Compensation Committee membership enhances cross-committee information flow; audit committee composed solely of independent directors.
    • Attendance at or above 75% threshold indicates baseline engagement.
    • Non-employee director pay structure is primarily pay-for-service (per-meeting cash) with a capped annual amount and a one-time equity grant, limiting ongoing equity dilution and aligning incentives.
  • Watch items:

    • Personal ownership stake is modest (<1%); while common for small-cap boards, investors may prefer additional open-market purchases to strengthen alignment.
    • The company proposes a substantial increase to the 2023 Equity Incentive Plan share reserve; while not director-specific, investors should monitor potential dilution and board stewardship of equity usage.
  • Related-party/conflicts:

    • The Nominating Committee’s remit includes developing and overseeing related-party transaction review policy; no specific related-party transactions involving Machinist are identified in the cited sections. Continue monitoring future proxies and 8-Ks for any transactions requiring audit/nominating committee review.